BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30837551)

  • 1. Nuclear FGFR2 negatively regulates hypoxia-induced cell invasion in prostate cancer by interacting with HIF-1 and HIF-2.
    Lee JE; Shin SH; Shin HW; Chun YS; Park JW
    Sci Rep; 2019 Mar; 9(1):3480. PubMed ID: 30837551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NDRG3 lowers the metastatic potential in prostate cancer as a feedback controller of hypoxia-inducible factors.
    Lee GY; Shin SH; Shin HW; Chun YS; Park JW
    Exp Mol Med; 2018 May; 50(5):1-13. PubMed ID: 29760417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NcoA2-Dependent Inhibition of HIF-1α Activation Is Regulated via AhR.
    Tsai CH; Li CH; Liao PL; Cheng YW; Lin CH; Huang SH; Kang JJ
    Toxicol Sci; 2015 Dec; 148(2):517-30. PubMed ID: 26350169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1alpha.
    Kallio PJ; Okamoto K; O'Brien S; Carrero P; Makino Y; Tanaka H; Poellinger L
    EMBO J; 1998 Nov; 17(22):6573-86. PubMed ID: 9822602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A ROS/STAT3/HIF-1α signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion.
    Cho KH; Choi MJ; Jeong KJ; Kim JJ; Hwang MH; Shin SC; Park CG; Lee HY
    Prostate; 2014 May; 74(5):528-36. PubMed ID: 24435707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HER2 regulates HIF-2α and drives an increased hypoxic response in breast cancer.
    Jarman EJ; Ward C; Turnbull AK; Martinez-Perez C; Meehan J; Xintaropoulou C; Sims AH; Langdon SP
    Breast Cancer Res; 2019 Jan; 21(1):10. PubMed ID: 30670058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.
    Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS
    Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HSulf-1 modulates FGF2- and hypoxia-mediated migration and invasion of breast cancer cells.
    Khurana A; Liu P; Mellone P; Lorenzon L; Vincenzi B; Datta K; Yang B; Linhardt RJ; Lingle W; Chien J; Baldi A; Shridhar V
    Cancer Res; 2011 Mar; 71(6):2152-61. PubMed ID: 21266348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIF-2alpha enhances beta-catenin/TCF-driven transcription by interacting with beta-catenin.
    Choi H; Chun YS; Kim TY; Park JW
    Cancer Res; 2010 Dec; 70(24):10101-11. PubMed ID: 21159632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CITED2 controls the hypoxic signaling by snatching p300 from the two distinct activation domains of HIF-1α.
    Yoon H; Lim JH; Cho CH; Huang LE; Park JW
    Biochim Biophys Acta; 2011 Dec; 1813(12):2008-16. PubMed ID: 21925214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DEC2 expression is positively correlated with HIF-1 activation and the invasiveness of human osteosarcomas.
    Hu T; He N; Yang Y; Yin C; Sang N; Yang Q
    J Exp Clin Cancer Res; 2015 Feb; 34(1):22. PubMed ID: 25884381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of hypoxia inducible factor-1α downregulates the expression of epithelial to mesenchymal transition early marker proteins without undermining cell survival in hypoxic lens epithelial cells.
    Cammarata PR; Neelam S; Brooks MM
    Mol Vis; 2015; 21():1024-35. PubMed ID: 26392741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia.
    Banham AH; Boddy J; Launchbury R; Han C; Turley H; Malone PR; Harris AL; Fox SB
    Prostate; 2007 Jul; 67(10):1091-8. PubMed ID: 17477366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hypoxic conditions.
    Chae KS; Kang MJ; Lee JH; Ryu BK; Lee MG; Her NG; Ha TK; Han J; Kim YK; Chi SG
    Oncogene; 2011 Mar; 30(10):1213-28. PubMed ID: 21057546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cAMP-dependent protein kinase is essential for hypoxia-mediated epithelial-mesenchymal transition, migration, and invasion in lung cancer cells.
    Shaikh D; Zhou Q; Chen T; Ibe JC; Raj JU; Zhou G
    Cell Signal; 2012 Dec; 24(12):2396-406. PubMed ID: 22954688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERRα augments HIF-1 signalling by directly interacting with HIF-1α in normoxic and hypoxic prostate cancer cells.
    Zou C; Yu S; Xu Z; Wu D; Ng CF; Yao X; Yew DT; Vanacker JM; Chan FL
    J Pathol; 2014 May; 233(1):61-73. PubMed ID: 24425001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGFR2 Promotes Gastric Cancer Progression by Inhibiting the Expression of Thrombospondin4 via PI3K-Akt-Mtor Pathway.
    Huang T; Liu D; Wang Y; Li P; Sun L; Xiong H; Dai Y; Zou M; Yuan X; Qiu H
    Cell Physiol Biochem; 2018; 50(4):1332-1345. PubMed ID: 30355943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stabilisation and knockdown of HIF--two distinct ways comparably important in radiotherapy.
    Ströfer M; Jelkmann W; Metzen E; Brockmeier U; Dunst J; Depping R
    Cell Physiol Biochem; 2011; 28(5):805-12. PubMed ID: 22178933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia inducible factor-1 is activated by transcriptional co-activator with PDZ-binding motif (TAZ) versus WWdomain-containing oxidoreductase (WWOX) in hypoxic microenvironment of bone metastasis from breast cancer.
    Bendinelli P; Maroni P; Matteucci E; Luzzati A; Perrucchini G; Desiderio MA
    Eur J Cancer; 2013 Jul; 49(11):2608-18. PubMed ID: 23566416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of hypoxia-inducible factor-1α and -2α in androgen insensitive prostate cancer cells.
    Jeong CW; Yoon CY; Jeong SJ; Hong SK; Byun SS; Kwak C; Lee SE
    Urol Oncol; 2013 Nov; 31(8):1448-56. PubMed ID: 22537539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.